# Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers

> **NCT00712283** · PHASE1 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 64 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Neramexane mesylate

## Key facts

- **NCT ID:** NCT00712283
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-06
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712283, "Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00712283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*